The application of nanotechnology to novel real-time diagnostics and anticancer drug design has demonstrated a significant impact on many areas of personalized nanomedicine. It is becoming increasingly more evident from the number of preclinical and ongoing clinical trials that nanotechnology will play a pivotal role in designing the next generation of self-assembled “smart” nanoparticles.
Perhaps one of the essential areas of applied research in personalized nanomedicine to move forward is the development of diagnostic and therapeutic multifunctional nanomaterials to help assign particular treatments and treatment schedules to individuals with diseases such as cancer. This innovative nanomedicinal concept, based on the idea of diagnostic and therapy combined in one “smart” nanoscale platform, is still evolving, yet considered to become particularly important in the modern therapy of malignant cancers. This strategy is addressed as the ‘‘find, fight, and follow’’ concept of early diagnosis, therapy, and therapy control, also known as ‘‘theranostics’’ in preclinical cancer nanotechnology.
MRI studies of rats (GEMNS project)